Interaction of endothelial cells and fibroblasts with modified fibrin networks: Role in atherosclerosis

Atherosclerosis

Volumn 129, Issue 1, 1997, Pages 9-15

  Shats, E A ^a   Nair, C H ^a   Dhall, D P ^a  

^a WODEN VALLEY HOSPITAL   (Australia)

Author keywords

endothelial cells; fibrin network structure; fibroblasts

Indexed keywords

FIBRIN; PLASMINOGEN ACTIVATOR INHIBITOR; PROSTACYCLIN; TISSUE PLASMINOGEN ACTIVATOR; VON WILLEBRAND FACTOR;

ARTICLE; ATHEROSCLEROSIS; CELL FUNCTION; CONTROLLED STUDY; ENDOTHELIUM CELL; FIBROBLAST; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ARTERIOSCLEROSIS; CELL DIVISION; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; EPOPROSTENOL; FIBRIN; FIBROBLASTS; HUMANS; HYDROGEN-ION CONCENTRATION; MICROSCOPY, PHASE-CONTRAST; PLASMINOGEN ACTIVATOR INHIBITOR 1; RISK FACTORS; TISSUE PLASMINOGEN ACTIVATOR; VON WILLEBRAND FACTOR;

EID: 0031055514     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(96)06003-0     Document Type: Article

References (19)

1. Smith EB, Thompson WD. Fibrin as a factor in atherosclerosis. Thromb Res 1994;73:1-19.
2. Smith EB, Keen GA, Grant A, Stirk C. Fate of fibrinogen in human arterial intima. Arteriosclerosis 1990;10:263-275.
3. Smith EB. Fibrinogen, fibrin and fibrin degradation products in relation to atherosclerosis. Clin Haematol 1986;15:355-370.
4. Schleef RR, Birdwell CR. Biochemical changes in endothelial cell monolayers induced by fibrin deposition in vitro. Arteriosclerosis 1984;3:14-20.
5. Ribes JA, Francis CW, Wagner DD. Fibrin induces release of von Willebrand factor from endothelial cells. J Clin Invest 1987;79:117-123.
6. Kaplan KL, Mather T, DeMarco L, Solomon S. Effect of fibrin on endothelial cell production of prostacyclin and tissue plasminogen activator. Arteriosclerosis 1989;9:43-49.
7. Mirshahi M, Azzarone B, Soria J, Mirshahi F, Soria C. The role of fibroblasts in organisation and degradation of a fibrin clot. J Lab Clin Med 1991;117:274-281.
8. Nair CH, Ali M, Tseytlina E, Dhall DP. Fibrinogen and fibrin gel characteristics as risk factors in vascular disease: role of lipids. Thromb Haemost 1993;69:807.
9. Fatah K, Hamsten A, Blomback B, Blomback M. Fibrin gel characteristics and coronary heart disease: relation to plasma fibrinogen concentration, acute phase protein, serum lipoproteins and coronary atherosclerosis. Thromb Haemost 1992;68:130-135.
10. Nair CH, Azhar A, Dhall DP. Studies on fibrin network structure in human plasma - Part one: methods for clinical application. Thromb Res 1991;64:455-476.
11. Dhall TZ, Bryce WAJ, Dhall DP. Effects of dextran on the molecular structure and tensile behavior of human fibrinogen. Thromb Haemost 1976;35:737-745.
12. Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins. Identification of morphology and immunologic criteria. J Clin Invest 1973;52:2745-2756.
13. Meier B, Radeke HH, Selle S et al. Human fibroblast release reactive oxygen species in response to interleukin-1 or tumor necrosis factor-α. Biochem J 1989;263:539-545.
14. Tranquille N, Emeis JJ. The simultaneous acute release of tissue-type plasminogen activator and von Willebrand factor in the perfused rat hindleg region. Thromb Haemost 1990;63:454-458.
15. Nair CH, Shah GA and Dhall DP. Effect of temperature, pH and ionic strength and composition on fibrin network structure and its development. Thromb Res 1986;42:809-816.
16. Kadish JL. Fibrin and atherogenesis - a hypothesis. Atherosclerosis 1979;33:409-413.
17. Kittlick PD. Fibrin in fibroblast cultures - a metabolic study as a contribution to inflammation and tissue repair. Exp Path 1979;17:312-326.
18. Brown LF, Lanir N, McDonagh J, Tognazzi K, Dvorak AM, Dvorak HF. Fibroblast migration in fibrin gel matrices. Am J Pathol 1993;142:273-283.
19. Kwaan HC, Astrup T. Tissue repair in presence of locally applied inhibitors of fibrinolysis. Exp Mol Pathol 1969;11:82-88.